Bromocryptine refers to a category of pharmaceutical compounds comprising the active pharmaceutical ingredient, its known impurities, metabolites, and stable isotope-labelled analogs. As a dopamine D2… Read more
Bromocryptine refers to a category of pharmaceutical compounds comprising the active pharmaceutical ingredient, its known impurities, metabolites, and stable isotope-labelled analogs. As a dopamine D2 receptor agonist and ergot alkaloid derivative, bromocryptine is primarily indicated for treating acromegaly and conditions linked to hyperprolactinemia, including infertility, hypogonadism, amenorrhea, and prolactin-secreting adenomas. Laboratories utilize these high-quality reference standards for rigorous quality control processes, including impurity profiling and the validation of analytical methods. Stable isotope-labelled bromocryptine compounds are essential tools in mass spectrometry-based quantitative analysis, providing reliable internal standards for measuring drug concentrations in complex biological matrices. By incorporating these materials into development and testing workflows, researchers can ensure accurate assessment of drug purity, stability, and pharmacokinetic profiles throughout the pharmaceutical manufacturing and clinical evaluation cycles.